Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 3
1957 4
1958 2
1959 1
1960 2
1963 2
1965 2
1966 2
1967 2
1968 8
1969 9
1970 10
1971 4
1972 8
1973 11
1974 12
1975 12
1976 10
1977 9
1978 22
1979 13
1980 12
1981 15
1982 12
1983 7
1984 11
1985 17
1986 37
1987 14
1988 6
1989 12
1990 9
1991 4
1992 10
1993 13
1994 14
1995 18
1996 14
1997 22
1998 28
1999 20
2000 19
2001 14
2002 20
2003 17
2004 17
2005 26
2006 30
2007 33
2008 29
2009 54
2010 46
2011 67
2012 66
2013 50
2014 48
2015 67
2016 70
2017 58
2018 72
2019 60
2020 86
2021 89
2022 112
2023 103
2024 98
2025 110
2026 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,740 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS Collaborators. Furuta S, et al. Among authors: inaba y. JAMA. 2021 Jun 1;325(21):2178-2187. doi: 10.1001/jama.2021.6615. JAMA. 2021. PMID: 34061144 Free PMC article. Clinical Trial.
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.
Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, Ohue M, Komori K, Shiomi A, Shiozawa M, Watanabe J, Suto T, Kinugasa Y, Takii Y, Bando H, Kobatake T, Inomata M, Shimada Y, Katayama H, Fukuda H; JCOG Colorectal Cancer Study Group. Kanemitsu Y, et al. Among authors: inaba y. J Clin Oncol. 2021 Dec 1;39(34):3789-3799. doi: 10.1200/JCO.21.01032. Epub 2021 Sep 14. J Clin Oncol. 2021. PMID: 34520230 Clinical Trial.
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.
Kudo M, Ueshima K, Saeki I, Ishikawa T, Inaba Y, Morimoto N, Aikata H, Tanabe N, Wada Y, Kondo Y, Tsuda M, Nakao K, Ito T, Hosaka T, Kawamura Y, Kuzuya T, Nojiri S, Ogawa C, Koga H, Hino K, Ikeda M, Moriguchi M, Hisai T, Yoshimura K, Furuse J, Arai Y. Kudo M, et al. Among authors: inaba y. Liver Cancer. 2023 Jun 5;13(1):99-112. doi: 10.1159/000531377. eCollection 2024 Feb. Liver Cancer. 2023. PMID: 38344448 Free PMC article.
2025 ICM: Decolonization.
Yildiz F, Ng MK, Abbaszadeh A, Lizcano JD, Alkhawashki HMI, Alzate R, Bingham JS, Bos K, Damioli LE, Del Toro MD, Fadel M, Goncalves SR, Grenho A, Higuera-Rueda CA, Hofstaetter J, Inaba Y, Incesoy MA, Kenanidis E, Martinez D, Mont MA, Morikane K, Norambuena GA, Palacio JC, Parvizi J, Pelt C, Riaz T, Schweitzer D, Seidelman J, Spangehl MJ, Suleiman L, Tarabichi S, Uchiyama K, Yayac M. Yildiz F, et al. Among authors: inaba y. J Arthroplasty. 2025 Dec;41(1S1):S53-S59. doi: 10.1016/j.arth.2025.10.096. Epub 2025 Oct 30. J Arthroplasty. 2025. PMID: 41176113 No abstract available.
Heterozygous missense variant of the proteasome subunit β-type 9 causes neonatal-onset autoinflammation and immunodeficiency.
Kanazawa N, Hemmi H, Kinjo N, Ohnishi H, Hamazaki J, Mishima H, Kinoshita A, Mizushima T, Hamada S, Hamada K, Kawamoto N, Kadowaki S, Honda Y, Izawa K, Nishikomori R, Tsumura M, Yamashita Y, Tamura S, Orimo T, Ozasa T, Kato T, Sasaki I, Fukuda-Ohta Y, Wakaki-Nishiyama N, Inaba Y, Kunimoto K, Okada S, Taketani T, Nakanishi K, Murata S, Yoshiura KI, Kaisho T. Kanazawa N, et al. Among authors: inaba y. Nat Commun. 2021 Nov 24;12(1):6819. doi: 10.1038/s41467-021-27085-y. Nat Commun. 2021. PMID: 34819510 Free PMC article.
Endoscopic ultrasound-guided vascular interventions.
Irisawa A, Nagashima K, Yamamiya A, Abe Y, Maki T, Kashima K, Kunogi Y, Fukushi K, Sakuma F, Inaba Y, Tominaga K. Irisawa A, et al. Among authors: inaba y. Dig Endosc. 2025 Jan;37(1):85-92. doi: 10.1111/den.14925. Epub 2024 Sep 25. Dig Endosc. 2025. PMID: 39319363 Review.
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Kodama Y, Ueshima K, Moriguchi M, Inaba Y, Yamashita T, Iwamoto H, Ueno M, Ogasawara S, Kuzuya T, Kodama T, Sato Y, Tada T, Tsuchiya K, Nishiofuku H, Yamakado K, Sone M, Ikeda M, Takehara T, Hamano T, Kudo M. Kodama Y, et al. Among authors: inaba y. BMC Cancer. 2025 Mar 11;25(1):434. doi: 10.1186/s12885-025-13648-5. BMC Cancer. 2025. PMID: 40069616 Free PMC article.
Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models.
Matsukawa T, Yagi T, Uchida T, Sakai M, Mitsushima M, Naganuma T, Yano H, Inaba Y, Inoue H, Yanagida K, Uematsu M, Nakao K, Nakao H, Aiba A, Nagashima Y, Kubota T, Kubota N, Izumida Y, Yahagi N, Unoki-Kubota H, Kaburagi Y, Asahara SI, Kido Y, Shindou H, Itoh M, Ogawa Y, Minami S, Terauchi Y, Tobe K, Ueki K, Kasuga M, Matsumoto M. Matsukawa T, et al. Among authors: inaba y. JCI Insight. 2023 Sep 8;8(17):e161282. doi: 10.1172/jci.insight.161282. JCI Insight. 2023. PMID: 37681411 Free PMC article.
1,740 results